Study | Device | Hemodynamic targets | Urine output threshold | Intervention |
---|---|---|---|---|
Not targeting urine output in either protocol | ||||
Sinclair 1997 [24] | esophageal Doppler | SV | Â | colloids |
Polonen 2000 [25] | Â | SvO2, Lactate | Â | fluids, dobutamine, vasoactive medication |
Rhodes 2002 [26] | PAC | PAWP | Â | fluid boluses, vasoactive agents |
Pearse 2005 [27] | LiDCO plus | SV, DO2I | Â | colloid, dopexamine |
Szakmany 2005 [28] | PiCCO | ITBVI | Â | crystalloid, colloid |
Wakeling 2005 [29] | esophageal Doppler | SV | Â | colloids |
Forget 2010 [30] | Masimo pulse oximeter | PVI | Â | colloids, vasoactive medication |
WenKui 2010 [31] | Â | Lactate | Â | crystalloids, colloids, dopamine, ephedrine |
Cecconi 2011 [32] | FloTrac/Vigileo | SV | Â | colloids, vasoactive medication, dobutamine |
Challand 2012 [33] | esophageal Doppler | SV | Â | colloid |
Bartha 2013 [34] | LiDCO | SV, DO2I | Â | fluids, vasoactive medication |
Bisgaard 2013 [35] | LiDCO | SVI | Â | colloids, dobutamine, vasoactive medication |
Lai 2015 [36] | LiDCO | SVV | Â | Colloids |
Targeting urine output only in CFM | ||||
Bishop 1995 [37] | PAC | DO2I, VO2I, CI | 30-50Â ml/h | volume, dobutamine |
McKendry 2004 [38] | esophageal Doppler | SI | no specific goal mentioned | colloids, blood, vasoactive medication |
Benes 2010 [39] | FloTrac/Vigileo | SVV | 0.5Â ml/kg/h | colloids, dobutamine |
Mayer 2010 [40] | FloTrac/Vigileo | CI, SVI | 0.5Â ml/kg/h | crystalloids, colloids, norepinephrine, dobutamine, vasodilators |
McKenny 2013 [41] | esophageal Doppler | SV | 0.5Â ml/kg/h | colloids |
Zakhaleva 2013 [42] | esophageal Doppler | SV, SVR, CO, FTc | 0.5-1.0Â ml/kg/h | colloids |
Osawa 2016 [43] | LIDCO | CI, SVI | 0.5Â ml/kg/h | crystalloid, dobutamine |
Targeting urine ouput in both protocols | ||||
Shoemaker 1988 [44] | PAC | Hct, PvO2, PAP, SVR, PWP, PVR, DO2, VO2 | 30Â mL/h | crystalloids, colloids, vasoactive medication |
Boyd 1993 [45] | PAC | DO2I | 0.5Â mL/kg/h | gelatin, dopexamine |
Gattinoni 1995 [46] | PAC | CI or SvO2 | 0.5Â mL/kg/h | fluids, vasoactive medication |
Lobo 2000 [47] | PAC | DO2 | 0.5Â mL/kg/h | fluids, dobutamine |
Rivers 2001 [48] | computerized spectrophotometer | ScvO2, MAP | 0.5Â mL/kg/h | crystalloid dobutamine, blood transfusions |
Chytra 2007 [49] | esophageal Doppler | SV, FTc | 1Â mL/kg/h | colloids |
Donati 2007 [50] | Â | SvO2, O2ERe | 0.5Â mL/kg/h | fluids, dobutamine |
Kapoor 2008 [51] | FloTrac/Vigileo | CVP, SVV | 1Â mL/kg/h | colloids, dopamine or other inotropes |
Senagore 2009 [52] | esophageal Doppler | SV | 0.5Â mL/kg/h | colloid |
Jammer 2010 [53] | Â | ScvO2 | 0.5Â mL/kg/h | crystalloids, colloid |
Jansen 2010 [54] | CeVOX | Lactate, ScvO2 | 0.5Â mL/kg/h | fluids, vasodilator therapy |
Jhanji 2010 [55] | LiDCO | SV | 25Â mL/h | fluids, dopexamine |
Bisgaard 2013 [56] | LiDCO | DO2I, SVI | 0.5–1.0 mL/kg/h | colloid, dobutamine |
Zheng 2013 [57] | FloTrac/Vigileo | CI, SVI, SV | 0.5Â mL/kg/h | balanced salt solution, colloid, dopamine / norepinephrine, nitroglycerin / ephedrine |
Peng 2014 [58] | FloTrac/Vigileo | SVV | 0.5Â mL/kg/h | Crystalloid, colloid, |
Correa-Gallego 2015 [59] | FloTrac/Vigileo | SVV | 25Â mL/h for 2 consecutive hours | Crystalloid, colloid, albumin bolus infusions |